Your session is about to expire
← Back to Search
Visual Stimuli and Brain Imaging for Memory Behavior
N/A
Waitlist Available
Led By Brice A Kuhl, Ph.D.
Research Sponsored by University of Oregon
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
For fMRI studies: For some sub-studies, individuals older than age 35 will be excluded because of potential differences in cognitive and brain function across age groups that are beyond the scope of the proposed studies. Individuals will be informed that use of psychoactive drugs, mental health disorders, and chronic or temporary sleep deficits (an average of less than 6 hours of sleep over the past month or less than 4 hours of sleep the night prior to the experimental session) are reasons for exclusion because of the potential influence on cognitive functioning
For behavioral studies: Potential participants will be informed that use of psychoactive drugs, mental health disorders, and chronic or temporary sleep deficits (an average of less than 6 hours of sleep over the past month or less than 4 hours of sleep the night prior to the experimental session) are reasons for exclusion because of the potential influence on cognitive functioning
Timeline
Screening 3 weeks
Treatment Varies
Follow Up data will be collected over a 5 year period. results from sub-studies will be analyzed within 6 months of the conclusion of data collection.
Awards & highlights
No Placebo-Only Group
Summary
This trial is recruiting healthy individuals from the University of Oregon and surrounding community to participate in behavioral, fMRI and eye tracking experiments that investigate human memory.
Who is the study for?
This trial is for healthy, right-handed native English speakers from the University of Oregon area. For behavioral studies, participants must be aged 18-35. For fMRI studies, they can be between 18-80 years old. People with mental health disorders, drug use or sleep deficits are excluded.
What is being tested?
The study investigates memory formation by having participants remember images while their brain activity and eye movements are tracked using fMRI and eye tracking technology. The similarity of images and learning methods will vary to see how it affects memory.
What are the potential side effects?
There may not be direct side effects from participating in this study since it involves non-invasive procedures like remembering images, fMRI scanning, and eye tracking which typically do not cause harm.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am under 35, don't use psychoactive drugs, have no mental health disorders, and sleep well.
Select...
I don't use psychoactive drugs, have mental health disorders, or suffer from chronic sleep deficits.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ data will be collected over a 5 year period. results from sub-studies will be analyzed within 6 months of the conclusion of data collection.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~data will be collected over a 5 year period. results from sub-studies will be analyzed within 6 months of the conclusion of data collection.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Behavior
eye tracking
fMRI pattern similarity
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Group I: fMRI pattern similarityExperimental Treatment2 Interventions
This arm will use fMRI and behavioral methods to test memory for different visual stimulus conditions.
Group II: eye trackingExperimental Treatment2 Interventions
This arm will use eye tracking and behavioral methods to test memory for different visual stimulus conditions.
Group III: BehavioralExperimental Treatment1 Intervention
This arm will use behavioral procedures to test memory for different visual stimulus conditions.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Eye tracking
2023
N/A
~50
Find a Location
Who is running the clinical trial?
University of OregonLead Sponsor
85 Previous Clinical Trials
43,457 Total Patients Enrolled
Brice A Kuhl, Ph.D.Principal InvestigatorUniversity of Oregon
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am under 35, don't use psychoactive drugs, have no mental health disorders, and sleep well.I am healthy, 18-35 years old, a native English speaker, and right-handed.I am healthy, aged 18-80, speak English natively, and am right-handed.I don't use psychoactive drugs, have mental health disorders, or suffer from chronic sleep deficits.
Research Study Groups:
This trial has the following groups:- Group 1: eye tracking
- Group 2: Behavioral
- Group 3: fMRI pattern similarity
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.